The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients [1]

American Journal of Human Genetics

Volumn 60, Issue 1, 1997, Pages 228-229

  Brulhart, M C ^a   Dussoix, P ^a   Ruiz, J ^a   Passa, P ^a   Froguel, P ^a   James, R W ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

DIABETIC ANGIOPATHY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE MUTATION; GENETIC RISK; GENOTYPE; HOMOCYSTINURIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; RISK FACTORS;

EID: 0031029698     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)